Calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint: case report and literature review

doi:10.19438/j.cjoms.2023.05.017

Abstract

Abstract: Calcium pyrophosphate dihydrate crystal deposition disease (CPPD) refers to calcium pyrophosphate crystals deposited in articular fibrocartilage, hyaline cartilage and its surrounding synovium, ligaments, tendons and joint capsules. CPPD is idiopathic in most patients, however, it has been associated with aging, osteoarthritis, gout, hyperparathyroidism and metabolic disorders like hemochromatosis and hypomagnesemia. In this paper, a female patient with CPPD of temporomandibular joint(TMJ) was reported,in which the lesion invaded cranial base, the condyle and disc of TMJ. Surgical procedure was performed to remove the lesion and reconstruct cranial base and TMJ.

Key words: Calcium pyrophosphate dihydrate crystal deposition disease, Temporomandibular joint, Condyle reconstruction

CLC Number:

R782.6

DENG Li-ni, CHEN Chuan-jun, WANG Yi, XIANG Xian-wang. Calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint: case report and literature review[J]. China Journal of Oral and Maxillofacial Surgery, 2023, 21(5): 522-525.

References

[1] Reijnierse M, Schwabl C, Klauser A.Imaging of crystal disorders: calcium pyrophosphate dihydrate crystal deposition disease, calcium hydroxyapatite crystal deposition disease and gout pathophysiology, imaging, and diagnosis[J]. Radiol Clin North Am, 2022, 60(4): 641-656.
[2] Meng J, Guo C, Luo H, et al.A case of destructive calcium pyrophosphate dihydrate crystal deposition diseaseof the temporomandibular joint: a diagnostic challenge[J]. Int J Oral Maxillofac Surg, 2011, 40(12): 1431-1437.
[3] Kudoh K, Kudoh T, Tsuru K, et al.A case of tophaceous pseudogout of the temporomandibular joint extending to the base of the skull[J]. Int J Oral Maxillofac Surg, 2017, 46(3): 355-359.
[4] Zhang W, Doherty M, Pascual E, et al.EULAR recommendations for calcium pyrophosphate deposition. Part II: management[J]. Ann Rheum Dis, 2011, 70(4): 571-575.
[5] 尹海波, 徐瑾, 王瑞琳, 等. 二水焦磷酸钙结晶沉积症60例临床病理分析[J]. 临床与实验病理学杂志, 2016, 32(11): 1267-1269.
Yin HB, Xu J, Wang RL, et al.A clinicopathological analysis of 60 cases of calcium pyrophosphate dihydrate crystallization deposition[J]. Chinese Journal of Clinical and Experimental Pathology, 2016, 32(11): 1267-1269.
[6] Mikami T, Takeda Y, Ohira A, et al.Tumoral calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint: identification on crystallography[J]. Pathol Int, 2008, 58(11): 723-729.
[7] Pendleton A, Johnson MD, Hughes A, et al.Mutations in ANKH cause chondrocalcinosis[J]. Am J Hum Genet, 2002,71(4):933-940.
[8] Zhang Y, Johnson K, Russell RG, et al.Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate[J]. Arthritis Rheum, 2005, 52(4): 1110-1117.
[9] Jubeck B, Gohr C, Fahey M, et al.Promotion of articular cartilage matrix vesiclemineralization by type Ⅰ collagen[J]. Arthritis Rheum, 2008, 58(9): 2809-2817.
[10] Kalya S, Rosenthal AK.Extracellular matrix changes regulate calcium crystal formation in articular cartilage[J]. Curr Opin Rheumatol, 2005, 17(3): 325-329.
[11] Abhishek A, Doherty M.Epidemiology of calcium pyrophosphate crystal arthritis and basic calcium phosphate crystal arthropathy[J]. Rheum Dis Clin North Am, 2014, 40(2): 177-191.
[12] Matsumura M, Hara S.Images in clinical medicine. crowned dens syndrome[J]. N Engl J Med, 2012, 367(23): e34.
[13] Miksanek J, Rosenthal AK.Imaging of calcium pyrophosphate deposition disease[J]. Curr Rheumatol Rep, 2015,17(3): 20-30.
[14] Terauchi M, Uo M, Fukawa Y, et al.Chemical diagnosis of calcium pyrophosphate deposition disease of the temporomandibular joint: a case report[J]. Diagnostics (Basel), 2022, 12(3): 651-660.
[15] Naqvi AH, Abraham JL, Kellman RM, et al.Calcium pyrophosphate dihydrate deposition disease (CPPD)/pseudogout of the temporomandibular joint-FNA findings and microanalysis[J]. Cytojournal, 2008,5(1): 8-13.
[16] Shidham V, Chivukula M, Basir Z, et al.Evaluation of crystals in formalin-fixed, paraffin-embedded tissue sections for the differential diagnosis of pseudogout, gout, and tumoral calcinosis[J]. Mod Pathol, 2001,14(8): 806-810.
[17] Reynolds JL, Matthew IR, Chalmers A.Tophaceous calcium pyrophosphate dihydrate deposition disease of the temporomandibular joint[J]. J Rheumatol, 2008, 35(4): 717-721.
[18] 李亚法, 王双义, 于晓宁. 颌面部焦磷酸钙沉积病并文献复习[J]. 海南医学, 2016, 27(23): 3946-3947.
Li YF, Wang SY, Yu XN.Maxillofacial calcium pyrophosphate deposition disease and literature review[J].Hainan Medical Journal, 2016, 27(23): 3946-3947.
[19] Richette P, Bardin T.Calcium pyrophosphate deposition disease[J]. Presse Med, 2011,40(9 Pt 1): 856-864.
[20] So PP, Tsui FW, Vieth R, et al.Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease[J]. J Rheumatol, 2007,34(6): 1313-1322.